Combining antigen-specific T cells with T-cell engager therapy induces a molecular signature that favors T-cell fitness
Abstract: Both adoptive cellular therapy with tumor antigen–specific T cells and redirection of endogenous T cells with bispecific tumor-specific T-cell engaging antibodies rely on CD8+ T cell effector function. The two approaches use complementary mechanisms of action (T-cell receptor [TCR]/major h...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2025-06-01
|
| Serier: | Blood Immunology & Cellular Therapy |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S3050597625000028 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
